Adlai Nortye Ltd. American Depositary Shares
Symbol: ANL (NASDAQ)
1.77
▼ (-1.61%) -0.029
Company Description:
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Key Stats
- Today's Open: $1.8
- Today's High: $1.8
- Today's Low: $1.771
- Today's Volume: 7.10K
- Yesterday Close: $1.8
- Yesterday High: $1.9127
- Yesterday Low: $1.73
- Yesterday Volume: 15.96K
- Last Min Volume: 2
- Last Min High: $1.79
- Last Min Low: $1.771
- Last Min VWAP: $1.79
Company Profile
- Name: Adlai Nortye Ltd. American Depositary Shares
- Website: https://www.adlainortye.com
- Listed Date: 2023-09-29
- Location: ,
- Market Status: Active
- CIK Number: 0001944552
- SIC Code:
- SIC description:
- Market Cap: $65.87M
- Round Lot: 100
- Outstanding Shares: 36.90M
- Asset Type: ADRC
RECENT FILINGS FOR ANL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-09 | 6-K | View |
| 2025-05-30 | 6-K | View |
| 2025-05-12 | 20-F/A | View |
| 2025-04-30 | 20-F | View |
| 2025-04-29 | SCHEDULE 13G | View |
| 2025-02-27 | UPLOAD | View |
| 2025-02-14 | 20-F/A | View |
| 2025-02-14 | 6-K | View |
| 2025-01-27 | CORRESP | View |
| 2025-01-02 | CORRESP | View |
| 2024-12-31 | 6-K | View |
| 2024-12-18 | UPLOAD | View |
| 2024-08-08 | 6-K | View |
| 2024-07-03 | 6-K | View |
| 2024-06-27 | 6-K | View |
| 2024-05-24 | 6-K | View |
| 2024-05-13 | S-8 | View |
| 2024-04-19 | 20-F | View |
| 2024-04-02 | 6-K | View |
| 2024-03-04 | SC 13G | View |
Latest News on ANL